Synapse

← JEADV Clinical Practice

Papers in JEADV Clinical Practice

Page 4 · newest first

  1. Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement CriteriaJEADV Clinical Practice · 2026
  2. Dermatological Manifestations of Glucagon‐Like Peptide‐1 Receptor AgonistsJEADV Clinical Practice · 2026
  3. Juvenile Mycosis Fungoides: A Multicenter Retrospective Italian StudyJEADV Clinical Practice · 2026
  4. Successful Treatment of Severe Adult Linear IgA Dermatosis Using DupilumabJEADV Clinical Practice · 2026
  5. Surgical Procedures and Medical Treatments Among Patients With Hidradenitis Suppurativa Before and After Referral to Specialised Dermatological Hospital Care: A Nationwide Registry StudyJEADV Clinical Practice · 2026
  6. Experiences of Drainage and Associated Impacts: A Qualitative Study Among Patients With Hidradenitis SuppurativaJEADV Clinical Practice · 2026
  7. A Refractory Leg Skin Ulcer Associated With Multiple Myeloma Successfully Treated With Plasma Exchange, Lenalidomide, and DexamethasoneJEADV Clinical Practice · 2026
  8. New Biologic and Small Molecule Therapies for Hidradenitis SuppurativaJEADV Clinical Practice · 2026
  9. Serum and Fecal Calprotectin Levels Do Not Alter Significantly in Patients With Psoriasis Switching to Brodalumab After Loss of Effect From TNF‐α InhibitorsJEADV Clinical Practice · 2026
  10. Efficacy of Ritlecitinib for Vitiligo Treatment Stratified by Baseline Demographic and Clinical Characteristics: Post Hoc Analysis of a Phase 2b StudyJEADV Clinical Practice · 2026
  11. Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart ReviewJEADV Clinical Practice · 2026
  12. Granulomatous Panniculitis in a Patient Treated With Cemiplimab: Case Report and Literature ReviewJEADV Clinical Practice · 2026
  13. Categorization of Reasons for Hospitalizations in Patients With Cutaneous T‐Cell LymphomaJEADV Clinical Practice · 2026
  14. Identification of Predictive Factors for Isolated Brain Progression in Patients With Cerebral Metastatic Melanoma After Treatment With Stereotactic Brain RadiotherapyJEADV Clinical Practice · 2025
  15. Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A ReviewJEADV Clinical Practice · 2025
  16. Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐ClavulanateJEADV Clinical Practice · 2025
  17. Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)JEADV Clinical Practice · 2025
  18. Beta Human Papillomaviruses Seropositivity and the Association With Cutaneous Squamous Cell Carcinoma—A Systematic Review and Meta‐AnalysisJEADV Clinical Practice · 2025
  19. Epidemiology of Pemphigus in MoroccoJEADV Clinical Practice · 2025
  20. Clinical Efficacy and Safety of Topical Roflumilast in Psoriasis: An Updated Systematic Review and Meta‐Analysis of Randomized Controlled TrialsJEADV Clinical Practice · 2025
  21. Eczema Monkeypoxicum Following Sexual Transmission Treated With TecovirimatJEADV Clinical Practice · 2025
  22. Patient‐Reported Outcomes Selected by Paediatric Patients With Atopic Dermatitis in the Aiming High in Eczema/Atopic Dermatitis ApproachJEADV Clinical Practice · 2025
  23. Response to Oral Dapsone in a Patient With Generalised Junctional Epidermolysis BullosaJEADV Clinical Practice · 2025
  24. Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature ReviewJEADV Clinical Practice · 2025
  25. Long‐Term Dermoscopic Evolution of Reticular Erythematous Mucinosis: Case ReportJEADV Clinical Practice · 2025
  26. Adjunctive Botulinum Toxin Type A for Bruxism and Sweat‐Worsened Facial Blistering in Recessive Dystrophic Epidermolysis Bullosa: A Case SeriesJEADV Clinical Practice · 2025
  27. Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort StudyJEADV Clinical Practice · 2025
  28. Bullae and Scales in a NewbornJEADV Clinical Practice · 2025
  29. Perceptions of a Group of Experts on the Integration of Artificial Intelligence in the Management of Atopic DermatitisJEADV Clinical Practice · 2025
  30. AI in Dermatology: Is Ireland Ready for the AI Revolution in 2025?JEADV Clinical Practice · 2025
  31. Useful Instruments for Psoriasis Patients’ Follow‐Up in Teleconsultation SettingJEADV Clinical Practice · 2025
  32. 73588 Borrelia and Genital Lichen Sclerosus: A Critical Review of the EvidenceJournal of the American Academy of Dermatology · 2025
  33. Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort StudyJEADV Clinical Practice · 2025
  34. Clinically Meaningful Improvements in Quality of Life, Including Sleep, With Two‐Week and Monthly Dosed Rademikibart: A Phase 2 Randomized Trial in Adults With Moderate‐to‐Severe Atopic DermatitisJEADV Clinical Practice · 2025
  35. Widespread Skin Lesions in an Italian ManJEADV Clinical Practice · 2025
  36. Undermined and Overlooked: A Diagnostic Challenge in the Gluteal CleftJEADV Clinical Practice · 2025
  37. Squamous Cell Carcinoma in Transporter Associated With Antigen Processing DeficiencyJEADV Clinical Practice · 2025
  38. Persistent Facial Nodules in an Elderly PatientJEADV Clinical Practice · 2025
  39. First Report of Homozygous COL7A1 c.5756delG Mutation Causing Recessive Dystrophic Epidermolysis Bullosa in a Non‐Consanguineous Japanese FamilyJEADV Clinical Practice · 2025
  40. A Case of Pembrolizumab‐Induced Pityriasis Lichenoides‐Like Eruption Treated Successfully With DupilumabJEADV Clinical Practice · 2025
  41. Prevalence and Burden of Somatic Symptom Disorder in Atopic Dermatitis and Chronic Pruritus—The Persistent Somatic Symptoms Across Diseases: Pruritus (SOMA.PRU) StudyJEADV Clinical Practice · 2025
  42. Skin of Color Representation in Hidradenitis Suppurativa TextbooksJEADV Clinical Practice · 2025
  43. Non‐Epidemic Kaposi Sarcoma Refractory to Laser Therapy in an HIV‐Negative Man Who Has Sex With Men (MSM)JEADV Clinical Practice · 2025
  44. Paraneoplastic Florid Oral Papillomatosis and Malignant Acanthosis Nigricans Associated With HPV‐Related Squamous Cell Carcinoma of Unknown PrimaryJEADV Clinical Practice · 2025
  45. Performance of a Deep Learning Algorithm for Melanoma Classification Across Diverse Dermoscopic and Tele‐Dermatology DatasetsJEADV Clinical Practice · 2025
  46. Health‐Related Quality of Life in Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis: A Qualitative StudyJEADV Clinical Practice · 2025
  47. Delayed Time to First Skin Cancer Among Hematopoietic Stem Cell Transplant Recipients With Chronic Cutaneous Graft‐Versus‐Host DiseaseJEADV Clinical Practice · 2025
  48. Atopic Comorbidities Associated With Chronic Spontaneous Urticaria: A Case‐Control Analysis of the All of Us Research ProgramJEADV Clinical Practice · 2025
  49. Artificial Intelligence‐Based Quantification to Assess the Automatic Psoriasis Area and Severity IndexJEADV Clinical Practice · 2025
  50. Necrotising Infundibular Crystalline Folliculitis: A Rare Case With a Microscopic Abundance of YeastsJEADV Clinical Practice · 2025